Product
mFOLFOX6 + Bevacizumab + PD-1 monoclonal antibody
1 clinical trial
2 indications
Indication
Colorectal CancerIndication
ImmunotherapyClinical trial
Safety and Efficacy of mFOLFOX6+ Bevacizumab+PD-1 Monoclonal Antibody Treatment Combinations in Patients With Local Advanced Microsatellite Stability Colorectal Cancer --an Open Label, Multicenter, Prospective Phase Ⅱ Study (BASKETII)Status: Recruiting, Estimated PCD: 2024-05-01